Growth-inhibitory effects of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitro
- 1 January 1994
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 120 (S1) , S3-S10
- https://doi.org/10.1007/bf01377114
Abstract
Coumarin (1,2-benzopyrone) is a natural substance that has shown antitumor activity in vivo. The major human metabolite of coumarin, 7-hydroxycoumarin (7-HC), is the active form of the drug. While the exact mechanism(s) of action of coumarin is unknown, it has been shown previously that this drug possesses immunomodulatory activity in vitro and in vivo. The present investigations examined the direet (non-immunological) antitumor effects of coumarin and 7-HC in vitro. Both coumarin and 7-HC were found to be growth-inhibitory (cytostatic) for the following human malignant cell lines: A549, ACHN, Caki-2, Dakiki, HS-Sultan, H727, HCT-15, HL-60, K562, LNCaP, PC-3, Du 145 COLO-232, MCF-7 and RP-1788. The growth inhibition was dependent on dose and time and was reversible upon removal of cells from medium containing the drug. Coumarin and 7-HC inhibited [3H]thymidine, [3H]uridine and [3H]leucine incorporation. In a similar fashion, coumarin and 7-HC inhibited the intracellular production of prostate-specific antigen by LNCaP cells. Coumarin and 7-HC stimulated apoptosis in HL-60 cells but not in other cell lines tested. It is concluded that coumarin and 7-HC have direct antitumor (cytostatic) activity as well as immunomodulatory activity. Further information is needed in order to determine which activities are responsible for antitumor activity in vivo.Keywords
This publication has 22 references indexed in Scilit:
- Phase II evaluation of coumarin (1,2‐benzopyrone) in metastatic prostatic carcinomaThe Prostate, 1992
- Synergistic effect of coumarin (1,2 benzopyrone) and endotoxin in the induction of human interleukin-1Clinical and Experimental Immunology, 1991
- Dose‐dependent induction of apoptosis in human tumour cell lines by widely diverging stimuliCell Proliferation, 1991
- Cimetidine and Coumarin Therapy of Renal Cell CarcinomaOncology, 1991
- Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic culturesNature, 1989
- High-efficiency preparation of DNA from limiting quantities of eukaryotic cells for hybridization analysisGene, 1987
- Combination of Cimetidine with Other Drugs for Treatment of CancerNew England Journal of Medicine, 1983
- The effect of coumarin derivatives on the immunological system of manInflammation Research, 1983
- CIMETIDINE AND COUMARIN THERAPY OF MELANOMAThe Lancet, 1982
- Pilot Study on Bioavailability of Coumarin and 7‐Hydroxycoumarin upon Peroral Administration of Coumarin in a Sustained‐Release Dosage FormThe Journal of Clinical Pharmacology, 1981